Trends in practice and outcomes from 2011 to 2015 for surgical aortic valve replacement: an update from the German Aortic Valve Registry on 42 776 patients.

Fujita, Buntaro; Ensminger, Stephan; Bauer, Timm; Möllmann, Helge; Beckmann, Andreas; Bekeredjian, Raffi; Bleiziffer, Sabine; Schäfer, Elke; Hamm, Christian W; Mohr, Friedrich W; Katus, Hugo A; Harringer, Wolfgang; Walther, Thomas; Frerker, Christian

doi:10.1093/ejcts/ezx408

2018

Back
Back to start of result list
Permanent link for displayed object

Title:: Trends in practice and outcomes from 2011 to 2015 for surgical aortic valve replacement: an update from the German Aortic Valve Registry on 42 776 patients.
Document type:: Journal Article
Author(s):: Fujita, Buntaro; Ensminger, Stephan; Bauer, Timm; Möllmann, Helge; Beckmann, Andreas; Bekeredjian, Raffi; Bleiziffer, Sabine; Schäfer, Elke; Hamm, Christian W; Mohr, Friedrich W; Katus, Hugo A; Harringer, Wolfgang; Walther, Thomas; Frerker, Christian
Abstract:: OBJECTIVES: Surgical aortic valve replacement (sAVR) is coming under close scrutiny with the recent upswing in the use of less invasive approaches. The aim of this analysis was to identify current trends in patient selection, procedural characteristics and outcomes after sAVR in Germany. METHODS: We analysed data from 42 776 patients included in the German Aortic Valve Registry who underwent sAVR with and without coronary artery bypass surgery (CABG) between 2011 and 2015. Baseline, procedural and short-term outcome parameters were analysed. RESULTS: Of all registered patients, 26 618 (62.2%) underwent isolated sAVR and 16 158 (37.8%) sAVR + CABG. The median age was 72 years, and the median Society of Thoracic Surgeons Predicted Risk of Mortality (STS PROM) was 2.3%. From 2011 to 2015, there was a decline in STS PROM (2.4-2.2%, P < 0.001) and a decline in risk factors, such as pulmonary hypertension (9.1-3.2%, P < 0.001), occlusive arterial disease (19.6-17.7%, P = 0.003), mitral regurgitation ≥2° (10.6-7.6%, P < 0.001) and New York Heart Association Class III/IV (65.3-59.2%, P < 0.001). In-hospital mortality was 2.3%, 1.3% had disabling stroke, 0.4% residual aortic regurgitation ≥2°, and the incidence of new-onset pacemaker/implantable cardioverter-defibrillator implantation was 3.9%. There was an increase in the use of biological valves in patients <65 years (50.1-65.7%, P < 0.001), and the proportion of rapid deployment valves increased significantly (1.5-8.4%, P < 0.001) over the investigated time period. CONCLUSIONS: Both isolated sAVR as well as sAVR + CABG resulted in excellent in-hospital outcomes based on >42 000 patients treated between 2011 and 2015. The implementation of alternative treatment strategies has resulted in palpable changes in patient and device selection.
Journal title abbreviation:: Eur J Cardiothorac Surg
Year:: 2018
Journal volume:: 53
Journal issue:: 3
Pages contribution:: 552-559
Fulltext / DOI:: doi:10.1093/ejcts/ezx408
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/29190355
Print-ISSN:: 1010-7940
TUM Institution:: Klinik für Herz- und Gefäßchirurgie (Prof. Lange)
BibTeX

Occurrences:

mediaTUM Gesamtbestand Einrichtungen Schools TUM School of Medicine and Health Departments Clinical Medicine Lehr- und Forschungskooperationen mit den Kliniken und Instituten am Deutschen Herzzentrum Klinik für Herz- und Gefäßchirurgie (DHM) (Prof. Krane)2018